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Abstract
Purpose: The purpose of this study was to investigate the role of beam collimator rotation in Volumetric
Modulated Arc Therapy (VMAT) for craniospinal irradiation (CSI), and the impact on dose distribution in the
beam junctions.
Methods: Six adult patients were selected for the study. Six VMAT plans with different collimator angles were
generated for each patient. The patients were treated in supine position with two beam isocenters. The plans were
evaluated by analysis of Dose-Volume Histogram (DVHs) data for planning target volume (PTV) and organs at risk
(OAR), and conformity index (CI) and homogeneity index (HI) for the target. Dose distributions in the beam
junctions were examined carefully and experimentally validated in phantom, with measurement using an ion
chamber array and film.
Results: The mean values of HI and CI for the plans with different beam collimator angles were not significantly
different. The numbers of segments, monitor units (MUs) and the delivery time of the plans with 45° beam
collimator were obviously higher than those in plans with other beam collimator angles. When collimator angle for
both sets of beams were set at 0°, there was a 1 mm low dose gap measured in the junction region.
Conclusions: By setting the collimator angle to 45°, only two isocenters were needed for the treatment of a target
with the length up to 90 cm. The HI and CI of the plans were almost the same, regardless if the collimator angles
were at 0°. The collimator angles for at least one set of beams should be off 0° in order to avoid a dose gap in the
beam junction region.
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Background
Craniospinal irradiation (CSI) is a standard therapy for
some primary central nervous system (CNS) tumors like
medulloblastoma and ependymoma [1–5]. The trad-
itional CSI techniques are complicated; the patients in
prone position are uncomfortable thus with poor reprodu-
cibility, and with supine position it is rather difficult to ver-
ify the field junctions. In addition, the poor dose uniformity
in the region of field junction is often unacceptable
clinically. In recent years, various intensity modulated radi-
ation therapy (IMRT) techniques have been used for CSI
[2–4]. Helical tomotherapy can be a favorable treatment be-
cause it obviates the problem of field junction due to its na-
ture of beam delivery [1, 6–8]. The dosimetric advantages
of proton therapy were for CSI were also evaluated [9].
However, a special machine like a tomotherapy unit may
not be accessible for all patients. Due to relatively low inci-
dence of CSI cases, it is desirable to develop a robust treat-
ment technique for CSI using a conventional linear
accelerator with a multileaf collimator (MLC). Supine pos-
ition is preferred for its superior reproducibility. The least
sets of fields, or number of beam isocenters should be used
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as more field junctions would increase the time for patient
setup and junction verification, bring additional uncertainty
in the region of field junction, and possibly take longer
beam-on time to treat.
In this study we investigated the volumetric modulated
arc therapy (VMAT) technique for CSI incorporated
with collimator rotation, in order to limit the number of
field sets to two. A beam with 45° collimator angle can
cover the longest for a tube-like shape of target such as
the spine, as shown in Additional file 1: Figure S1.
A high-end digital linear accelerator Axesse® (Elekta
AB Stockholm, Sweden) equipped with the Agility® 160-
leaf MLC was used for patient treatment. The width of
all leaves is 5 mm at the isocenter plane. A distinguished
advantage for the Agility MLC is its low leaf and inter-
leaf transmission. The average MLC transmission for
6MV photon is 0.47 % (Table 1), vs. 1–2 % for other
commercial systems [10]. The impact on dose distribu-
tion in the field junction region with various collimator
angles, or directions of MLC leaf travel was evaluated
using accurate Monte-Carlo based dose calculation.
Methods
This study was approved by the Institutional Review
Board of our hospital, and written informed consents
were obtained from the patients before treatment. Six
adults (Four females, Two males) were treated with
6MV photon (Table 2). Patients were in supine position,
immobilized in a BodyFIX® vacuum cushion from head
to hip (Elekta AB, Stockholm, Sweden) with a headrest,
a knee support, and a thermoplastic mask. The planning
CT scan was acquired using a Siemens Somatom®
Sensation Open 40-slice CT scanner (Siemens Medical
Solutions, Forchheim, Germany). The slice thickness of
CT images was 3 mm. The image set was exported to a
Monaco Treatment Planning System (Monaco version
3.2, Elekta AB, Stockholm, Sweden) for planning.
Target delineation and dose prescription
The first clinical target volume (CTV), labeled as CTV1,
consisted of the whole brain, and the second CTV,
CTV2 consisted of the entire spinal canal with lateral
extensions to include part of the nerve roots. The plan-
ning target volumes (PTV), PTV1 and PTV2, were gen-
erated by uniformly expanding CTV1 and CTV2 with a
5 mm margin, respectively. The dose prescription was
36Gy in 20 fractions to at least 95 % of the total PTV
which consisted of PTV1 and PTV2.
Setup of arc beams
Two sets of beams were used for the PTV length in a
range of 68.1 cm to 80.7 cm (Table 2). The two beam
isocenters shared the same X and Z coordinates, as
those of the center of PTV. The shift in Y coordinate (in
the craniocaudal direction) was easily implemented with
a couch slide.
The PTV2 was a cylindrical structure with 6-8 cm diam-
eter for an adult patient. With a 25–30° collimator rotation
a target of 42 cm length could be covered, and with 45° col-
limator rotation a target of up to 48.5 cm long could be
covered, as shown in Additional file 1: Figure S1. By a con-
servative estimation, two abutting sets of arc beams with
Table 1 Parameters of the Axesse® linacs
Parameter Axesse®
Leaf width at isocenter (mm) 5
Field size, maximum (mm) 400
Leaf individual travel range (mm) 200 (with respect to DLGa)
Leaf and DLGa or backup jaw
combined travel range (mm)
350
Leaf interdigitation range (mm) 200
Diaphragm over-travel relative
to central axis (mm)
120
Height of leaf (mm) 90
Leaf and interleaf transmissions (6MV) 0.47 %
Diaphragm/jaw speed, maximum (mm/s) 90
Leaf speed, maximum (mm/s) 35
Leaf and DLG combined speed, maximum 65 mm/s
Speed of gantry rotation (/s) 6.0 degree/s
Dose rate, maximum (MU/min) Continuous, 660
aDLG Dynamic Leaf Guides. All leaves were integrated with two DLGs and they
traveled together





Fixation Thermoplastic mask, vacuum
bag and knee support
Patient’s height (cm) 152–175.6
Plans
Length of target (cm) 68.1–80.7
Height of target (cm) 13.1–15.6
Width of target (cm) 14.2–15.8
The number of isocenters 2
Distance between isocenters (cm) 35–41
Total dose prescription (Gy)/Fraction 36/20
Quality assurance
Device MatriXX plus MultiCube (IBA inc.)
EBT2 film (International Special
Products inc.)
Image guidance Cone-beam CT, daily
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45° collimator angle can cover a target for CSI as long as 90
cm, even considering the brain target of 20 cm width, and
the curved spinal target. Three beam isocenters may be
necessary when the length of the target is over 90 cm.
It is important to recognize the limit of leaf interdigi-
tation range of Agility® MLC, which is 20 cm. This
means that the maximum distance between any two leaf
ends on one side cannot not be larger than 20 cm. Thus
the MLC cannot conform to a target shape longer than
28.2 cm with the collimator angle at 45° (Fig. 1). A solu-
tion to this problem is to divide the PTV into several
parts. Each part has a length not greater than 24 cm.
Arc beams are arranged to treat individually each part of
the PTV. Therefore, only increased number of arc beams
are used which involve shifts of MLC leaf guides, but
not the number of beam isocenters.
VMAT planning
A full arc beam with the upper isocenter covered mainly
the head and neck part of the PTV. In order to reduce
the volume of body irradiated, the lower set of beams
irradiating the rest of the PTV consisted of 3 partial arcs:
180°–240°, 300°–60°, 120°–180°. This also led to better
sparing of lung, liver and intestine than using the full
arc, thereby reducing the toxicities of treatment.
An important issue to consider is how to match the
beams with more than one isocenter to guarantee a
smooth dose distribution in the junction region. A strat-
egy that employs at least 2 cm overlapping region between
beams with different isocenters was adopted [2–4]. The
VMAT optimizer in the Monaco treatment planning sys-
tem (TPS) would automatically produce a smooth dose
distribution in the beam junction region, which was care-
fully checked and verified.
The plan quality potentially influenced by different
beam collimator angles was investigated with different
combinations of beam collimator angles in 0°, 30° and
45° for the upper and lower sets of beams. Six plans
were generated for each patient which were named by
PAc0c0, PAc0c30, PAc0c45, PAc30c30, PAc30c45, and
PAc45c45. The detailed specification of these plans was
given in Table 3.
Plan evaluation
The plan quality with respect to PTV coverage and dose
received by organs at risk (OAR) was evaluated using
the dose-volume histogram (DVH) data. For the PTV,
the evaluated parameters were the mean dose, D2 and
D98, or the dose delivered to 2 % and 98 % of the PTV,
respectively, and V107%, or the volume in PTV receiving
107 % of the prescribed dose. A conformity index (CI)
and a homogeneity index (HI) were calculate for each







where VolTarget and VolRx are the PTV volume and the
volume receiving the prescription dose, respectively, and
DRx is the prescribed dose to the target. The ideal CI for
a plan is 1, and HI should be as small as possible.
In addition to the mean dose for each OAR, the lung
V5, percentage of lung volume receiving above 5 Gy, was
reported.
Quality assurance
An ionization chamber array (MatriXX, IBA Dosimetry,
Bartlett, TN) was used to measure the dose distribution
in a slab phantom (MultiCube) for validating the treat-
ment plans in this study. The dimensions of MultiCube
are 31.4 cm (L) x 34 cm (W) x 34 cm (H), and the
distance from the detector plane to the top surface is
Fig. 1 MLC conformed to a long target at 0° and 45° collimator angles. a, b collimator cannot conform well to the target of 36 cm long at 45°;
c, d 48 cm long target divided into two parts of 24 cm in length; d the lower half of the target is conformed well with the collimator at 45°
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11 cm. It was used to measure only the dose distribution
at one end of PTV. The electronic circuit part of MatriXX
must be kept away from direct irradiation to avoid being
damaged. Since none of the commercial QA devices is big
enough to cover the high dose region for CSI, the dose
distribution at the beam junctions was verified by EBT2
radiochromic film (International Speciality Products,
Wayne, NJ) placed in a water-equivalent slab phantom, as
shown in Additional file 2: Figure S2. The dimensions of
the phantom for film measurement were 90 cm (L) x 30
cm (W) x 20 cm (H). The film was placed at the depth
of 10 cm. For the film measurement, the phantom
was large enough to encompass the dose calculation
zone of the QA plans.
Setup errors were simulated by shifting the lower iso-
center with ±1, ±3, ±5 mm for the plan with all 0° colli-
mator angle which represent the worst case scenario at
the beam junctions. In addition to the set of 6 collimator
combinations, a few plans with 5° collimator rotation
were generated for assessing its effects on blurring the
dose in the field junctions.
Results
The planning parameters for the six plans and resulted
dose distribution parameters for the PTV and OARs are
shown in Table 4. There were no significant differences
among the mean doses for the PTV in all plans, and the
OAR doses, in general do not pose a concern. Also there
were no meaningful differences in HI, CI, the numbers
of segments, MUs and delivery times for the plans with
0° and 30° collimator angles. However, for the plans with
45° collimator angle, the increased number of beams led
to increased numbers of segments, MUs and the delivery
time. The mean HI and CI values were slightly lower
than that of the plans with 0° and 30° collimator angles.
The plan PAc45c45 had the highest numbers of seg-
ments, MUs and the longest delivery time. The mean
CIs for PTV2 were significantly lower than that for the
whole PTV.
The dose distributions in selected sagittal and trans-
versal planes for one patient are shown in Fig. 2. The
dose distribution was somewhat elongated in the antero-
posterior direction.
Figure 3 showed pronounced dose difference as the
longitudinal shift of the lower isocenter reached 3 mm
and greater. Furthermore, there was roughly a 1 mm
lower dose gap between the beams with different isocen-
ters. This gap disappeared when the collimator angle
was off 0° for at least one set of beams, as seen in Fig. 4.
The dose distributions in the beam overlapping region
were exhibited in Fig. 4e and f. The beam penumbras
were enlarged significantly in the overlapping region.
Discussion
As previously reported by a few studies on the applica-
tion of VMAT for CSI [2–4], VMAT showed advantages
in improved dose conformity and homogeneity, as well
as fast treatment delivery, compared to conventional
non-IMRT techniques. The difficulty in field junction
matching was resolved by inverse planning with a
modern TPS automatically and reliably accurate dose
calculation.
However, there is still a need for a consented common
clinical or planning guidelines for CSI using VMAT. In
the study by Fogliata et al. [3], five patients underwent
CSI were treated in 5 different institutes. Two of them
were supine and the others were prone, and the
immobilization techniques were also different. The plan
optimization technique also varied. In addition, three
sets of beams with different isocenters were used for 3
patients, even though the maximum target length was
only 78.4 cm.
Undoubtedly, patients will be more comfortable in su-
pine position than prone. The thermoplastic mask, knee
support and vacuum bag for the body can all contribute
to improving patient immobilization and therefore target
localization, especially for a long target in CSI.
A beam with 45° collimator angle can cover a 48.5 cm
long target. Thus even a target of 90 cm long in CSI can
be treated by beams with two isocenters. Table 4 indi-
cates that there was little difference in plan quality
among the plans with different combinations of beam
collimator angles. Two sets of beams with 30° collimator
angle were enough for the 80.7 cm long target. This only
involved one field junction, and the couch moved only
once during the treatment. Using two beam isocenters
avoided added uncertainties associated with one more
beam setup.
Figure 3 showed the dose distributions in the junc-
tion region when the collimator angle of the beams
was at 0°. A 3 mm longitudinal error of the lower
isocenter led to more than 20 % difference in the
Table 3 The specification of the treatment plans
Beam collimator anglea Number of
arc beamsPlan name Upper isocenter Lower isocenter
PAc0c0b 0° 0° 4
PAc0c30 0° 30° 4
PAc0c45 0° 45° 7c
PAc30c30 30° 30° 4
PAc30c45 30° 45° 7c
PAc45c45b 45° 45° 7c
aThere were 2 beam isocenters in this study
bThe patient whose PTV was 80.7 cm long was excluded for PAc0c0 and PAc45c45
cThere were six partial arc beams with lower isocenter when there was 45
collimator angle. The target covered by the beams with the lower isocenter
was divided into two parts then the beams conformed to them respectively
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dose distribution. The middle three distributions
corresponding to 0 and ±1 mm isocenter shifts were
all acceptable. The typical mechanical accuracy for
couch position with a modern linac is on the order
of 1 mm [4]. So with reliable patient immobilization
the dose errors in the junction region could be well
within clinical tolerance. It is interesting to observe a
small dose gap around 3 % when there was no artifi-
cially introduced setup error, as shown by the middle
plot in Fig. 3. There are several reasons for the low dose
Table 4 Dose statistics for the PTV and OARs, and treatment planning parameters for plans
Target Parameters PAc0c0 PAc0c30 PAc30c30 PAc0c45 PAc30c45 PAc45c45
PTV Mean (cGy) 3753.2 ± 44.8 3721.5 ± 60.2 3718.6 ± 38.8 3738.5 ± 32.9 3741.4 ± 55.7 3735.5 ± 31.4
D95 % (cGy) 3600 3600 3600 3600 3600 3600
D2 % (cGy) 3908.6.2 ± 41.2 3936.4 ± 35.2 3937.1 ± 39.8 3928.1 ± 47.3 3941.1 ± 51.7 3951.1 ± 56.6
D98 % (cGy) 3520.3 ± 22.5 3528.4 ± 28.9 3538.3 ± 26.4 3529 ± 21.7 3518.2 ± 25.7 3532 ± 20.2
V107 % 8.9 ± 2.5 % 9.1 ± 3.2 % 9 ± 3.5 % 9.2 ± 3.4 % 9.1 ± 2.8 % 9.3 ± 3.7 %
Lenses Mean (Gy) 6.93 ± 0.41 6.88 ± 0.45 7.08 ± 0.55 6.95 ± 0.57 6.96 ± 0.82 7.11 ± 0.63
Optic nerves Mean (Gy) 21.2 ± 2.76 21.4 ± 2.26 21.2 ± 2.55 22.1 ± 2.89 21.3 ± 2.68 21.9 ± 3.11
Parotids Mean (Gy) 12.66 ± 1.82 13.15 ± 1.97 12.16 ± 1.88 13.06 ± 1.9 13.4 ± 1.72 13.27 ± 1.43
Thyroid Mean (Gy) 12.88 ± 2.19 12.91 ± 2.37 12.42 ± 2.84 12.28 ± 2.41 13.44 ± 2.77 13.05 ± 2.76
Lungs V5 % 42.1 ± 7.66 % 42.8 ± 7.52 % 43.6 ± 8.58 % 44.2 ± 8.64 % 45.1 ± 8.09 % 44.7 ± 8.60 %
Mean (Gy) 6.24 ± 0.52 6.46 ± 0.78 6.41 ± 0.83 6.38 ± 0.77 6.33 ± 0.29 6.51 ± 0.44
Esophagus Mean (Gy) 15.1 ± 2.9 15.7 ± 2.2 15.5 ± 2.36 14.8 ± 2 15.3 ± 2.86 15.8 ± 2.11
Heart Mean (Gy) 6.3 ± 1.58 6.1 ± 2.05 6.1 ± 2.95 6.5 ± 2.5 6.4 ± 2.8 6.2 ± 2.34
Liver Mean (Gy) 5.31 ± 0.52 5.22 ± 0.88 5.45 ± 0.85 5.36 ± 0.49 5.1 ± 0.73 5.62 ± 0.76
Kidneys Mean (Gy) 4.85 ± 0.65 4.92 ± 0.74 4.9 ± 0.53 5.02 ± 0.81 4.92 ± 0.69 5.23 ± 0.8
Planning parameters
Number of arc beams 4 4 4 7 7 7
Segments 236.9 ± 8.2 239.3 ± 6.4 241.7 ± 6.3 278.7 ± 5.3 277.4 ± 7.6 285.3 ± 8.8
Mus 1033.6 ± 55.3 1064.1 ± 39.8 1028.5 ± 61.4 1316.3 ± 78.1 1335.4 ± 56.7 1393.8 ± 51.4
Delivery time (s)* 233.9 ± 16.4 236.3 ± 13.5 239.2 ± 15.7 310.7 ± 25.6 313.2 ± 18.1 323.9 ± 15.8
HI 10.96 ± 1.6 % 10.99 ± 1.4 % 11.05 ± 1.7 % 11.25 ± 1.6 % 11.2 ± 2.9 % 11.58 ± 1.9 %
CI (whole PTV) 90.6 ± 2 % 90.5 ± 2.4 % 90.1 ± 2.4 % 89.1 ± 3.1 % 88.6 ± 2.9 % 87.5 ± 1.9 %
CI (Spine only) 69.2 ± 3 % 68.5 ± 3.3 % 68.6 ± 3 % 67.2 ± 2.1 % 65.8 ± 2.4 % 66.1 ± 2.3 %
* Delivery time: included the beam-on, the gantry and collimator rotation between arc beams, not the shift between isocenters
Fig. 2 Dose distributions in selected transversal and sagittal planes for a patient (PlanAxesse). Color wash range: 1500-3750cGy (Maximum
dose: 3952.6cGy); red crosses and arcs: beam isocenters and arc beams; blue crosses: points on the axis through two beam isocenters
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gap, including the couch position error, and the beam
model for a large field penumbra may not be perfect
as the modeling of jaw transmission also comes into
play, especially when the collimator angle is set to 0°.
The dose gap was revealed by film measurement,
which provided a high spatial resolution. The gap was
not seen in the TPS calculated dose distribution. A
fast X-ray voxel Monte Carlo algorithm [12–14] was
adopted in the TPS but it still took over 5 h with a
dose grid of 3 mm × 3 mm × 3 mm. Using a finer
dose grid with our current hardware was not practical
for such a large target volume.
The dose distribution in the field junction region
with different combinations of the beam collimator
angles are shown in Fig. 4. It was interesting that the
aforementioned gap disappeared as the collimator
angle was not zero for at least one set of beams. Even
5° collimator angle was enough to make the gap to
disappear. The major reason for this might be due to
the broadened beam penumbra when the collimator
angle was off 0°. When the collimator angle was up
to 30° and more, the overlap regions between fields
were expanded substantially. For example, with 35 cm
separation between two isocenters, the field overlaps were
Fig. 3 Dose distributions by film measurement at the junction region of arc beams with two isocenters. The collimator angles were at 0°. The
dose was normalized to 180cGy. From top to bottom: the Y coordinate of the lower isocenter was shifted −5, −3, −1, 0, 1, 3, 5 mm, respectively
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about 2.5 cm and 4 cm for 0°/0° and 30°/30° collima-
tor angle combinations, respectively. The beam pen-
umbras were clearly broadened in the overlapping
regions (Fig. 4e, f ). Similar results were also found by
Chen [4]. In his study, the collimator angles of the
upper and lower arc beams were 5° and 355°, respect-
ively. A longitudinal shift of ±3 mm for the lower iso-
center led to less than 15 % dose errors in the
junction region. The dose distribution at the field
junction may also be dependent on the different
linear accelerators or different TPS used.
Although VMAT is known to offer advantageous dose
distribution over conventional three-dimensional con-
formal radiotherapy and IMRT [2], one should recognize
an increased volume of healthy tissue being irradiated
with VMAT. We used three partial arcs with the lower iso-
center in order to reduce the volume of body irradiated. As
a consequence the dose distribution was slightly elongated
in the anteroposterior direction (Fig. 2). Overall, the results
of this study, including the patient whose target was
80.7 cm long, were compatible to those reported in
other studies, but all our patients were treated with
only two beam isocenters. An increased numbers of
segments, MUs and delivery time in the plans with
45° beam collimator angle were reasonable, consider-
ing the large target volume and the alternative of
using three beam isocenters.
Conclusion
A highly conformal and homogeneous VMAT planning
technique for CSI using an Axesse® linear accelerator
was developed. By setting the collimator angles to 45°,
only two beam isocenters were needed for treating a tar-
get with length up to 90 cm. The plan quality was basic-
ally same, regardless of the beam collimator angle used.
Setting the collimator angle off 0° for at least one set of
beams could make the plan less susceptible to
localization error of the beam isocenter.
Fig. 4 Dose distributions in the junction regions of arc beams with different isocenters and collimator angles. The upper and lower parts were
the measured (by films) and calculated dose distributions, respectively. From Part a to Part f: the collimator angles of the upper and lower arc
beams were 0°/0°, 0°/5°, 30°/30°, 45°/45°, 0°/NA, 30°/NA, respectively. The Part e and Part f were the dose distributions of the beams with the
upper isocenter. The dose was normalized to 180cGy
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Additional files
Additional file 1: Figure S1. A 40 cm× 40 cm field with a 45° collimator
angle. (TIF 15 kb).
Additional file 2: Figure S2. The sketch of dose distribution verification
in fields’ junction with films. The film was placed in the middle of square,
slab phantoms, which was placed in the middle of two arc beam
isocenters. The distance of two isocenters was 350 mm. (JPG 39 kb).
Abbreviations
3D CRT: three-dimensional conformal RT; CI: conformity index;
CSI: craniospinal irradiation; CTV: clinical target volume; DLG: dynamic leaf
guides; DVH: dose-volume histogram; HI: homogeneity index; IMRT: intensity
modulated radiation therapy; MLC: multileaf collimator; OAR: organ-at-risk;
PTV: planning target volume; QA: quality assurance; TPS: treatment planning
system; V5 for lung: the percentage lung volume receiving 5 Gy;
VMAT: volumetric modulated arc therapy.
Competing interests
The authors declare that they have no conflicts of interest.
Authors’ contributions
HP, WG and QL conceived the experiments. QL and JM designed the
experiments. WY, MG and JM performed the experiments. QL, WY, MG
collected the data and performed the statistical analysis. QL and MG prepared
the manuscript. All authors read and approved the final manuscript.
Acknowledgements
The authors thank the help from the physicists and Medical Affairs of Elekta
AB f in this study.
Received: 7 April 2015 Accepted: 27 October 2015
References
1. Brown AP, Barney CL, Grosshans DR, McAleer MF, de Groot JF, Puduvalli VK,
et al. Proton beam craniospinal irradiation reduces acute toxicity for adults
with medulloblastoma. Int J Radiat Oncol Biol Phys. 2013;86(2):277–84.
2. Studenski MT, Shen X, Yu Y, Xiao Y, Shi W, Biswas T, et al. Intensity-modulated
radiation therapy and volumetric-modulated arc therapy for adult craniospinal
irradiation–a comparison with traditional techniques. Med Dosim.
2013;38(1):48–54.
3. Fogliata A, Bergstrom S, Cafaro I, Clivio A, Cozzi L, Dipasquale G, et al.
Cranio-spinal irradiation with volumetric modulated arc therapy: a multi-
institutional treatment experience. Radiother Oncol. 2011;99(1):79–85.
4. Chen J, Chen C, Atwood TF, Gibbs IC, Soltys SG, Fasola C, et al. Volumetric
modulated arc therapy planning method for supine craniospinal irradiation.
J Radiat Oncol. 2012;1(3):291–97.
5. Michalski JM, Klein EE, Gerber R. Method to plan, administer, and verify
supine craniospinal irradiation. J Appl Clin Med Phys. 2002;3(4):310–6.
6. Guerra JLL, Marrone I, Jaen J, Bruna M, Sole C, Sanchez-Reyes A, et al.
Outcome and toxicity using helical tomotherapy for craniospinal irradiation
in pediatric medulloblastoma. Clin Transl Oncol. 2014;16(1):96–101.
7. Prados MD, Wara WM, Edwards MS, Cogen PH. Hyperfractionated
craniospinal radiation therapy for primitive neuroectodermal tumors: early
results of a pilot study. Int J Radiat Oncol Biol Phys. 1994;28(2):431–8.
8. Sugie C, Shibamoto Y, Ayakawa S, Mimura M, Komai K, Ishii M, et al.
Craniospinal irradiation using helical tomotherapy: evaluation of acute
toxicity and dose distribution. Technol Cancer Res Treat. 2011;10(2):187–95.
9. Yoon M, Shin DH, Kim J, Kim JW, Kim DW, Park SY, et al. Craniospinal
irradiation techniques: a dosimetric comparison of proton beams with
standard and advanced photon radiotherapy. Int J Radiat Oncol Biol Phys.
2011;81(3):637–46.
10. Pasquino M, Borca VC, Catuzzo P, Ozzello F, Tofani S. Transmission,
penumbra and leaf positional accuracy in commissioning and quality
assurance program of a multileaf collimator for step-and-shoot IMRT
treatments. Tumori. 2006;92(6):511–6.
11. Li Q, Pei H, Mu J, Hu Q, Gu W. Segment edit and segment weight
optimization: two techniques for intensity modulated radiation therapy and
their application to the planning for nasopharyngeal carcinoma.
Technol Cancer Res Treat. 2013;12(5):403–9.
12. Fippel M. Fast Monte Carlo dose calculation for photon beams based on
the VMC electron algorithm. Med Phys. 1999;26(8):1466–75.
13. Fippel M, Haryanto F, Dohm O, Nusslin F, Kriesen S. A virtual photon energy
flence model for Monte Carlo dose calculation. Med Phys. 2003;30(3):301–11.
14. Sikora M, Dohm O, Alber M. A virtual photon source model of an Elekta
linear accelerator with integrated mini MLC for Monte Carlo based IMRT
dose calculation. Phys Med Biol. 2007;52(15):4449–63.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Li et al. Radiation Oncology  (2015) 10:235 Page 8 of 8
